Pharmacist Counseling Cuts Chemotherapy Admissions in Single-Center QI Study

This pre-post quality improvement project quantifies the admission, satisfaction, and cost-avoidance impact of a structured pharmacist-led chemotherapy counseling service, offering a practical implementation model despite its uncontrolled design.

pharmacist-led counselingoncology pharmacychemotherapyhospital admissionsfebrile neutropeniacost avoidancepatient satisfactionquality improvementsupportive carepre-post study Oncology Pharmacy

Background Information

Pharmacist-led counseling slashes chemo admissions and boosts satisfaction.

This study shows how pharmacist-led counseling can significantly improve outcomes for chemotherapy patients. The intervention reduced hospital admissions by 34.4%, achieved 94.4% patient satisfaction, and saved $38,850 in costs over five months. Integration of structured pharmacist-led counseling in oncology could reduce admissions and improve patient satisfaction significantly. Pharmacist-led counseling cuts chemotherapy admissions and boosts satisfaction, proving economical.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Assiri A, Median IA, Alshahrani K, Asiri M, Alsaeed O, Asiri A, Abashar M, Ali M, Alsraeya A

Citation: Assiri A, Median IA, Alshahrani K, et al. Pharmacist-led Chemotherapy Counseling: Impact on Hospital Admissions, Patient Satisfaction, and Cost Avoidance - A Prospective Pre-post Quality Improvement Study. Journal of research in pharmacy practice. 2026;15(1):33. doi:10.4103/jrpp.jrpp_24_26

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →